
Holly Wade: A Legacy of Light and Love
Holly Ann Wade was a remarkable young woman whose light continues to shine through the impact she made in her fourteen years. Diagnosed with gliosarcoma, a rare and aggressive form of brain cancer, Holly faced her illness with incredible courage, grace, and resilience. Her journey was one of strength, perseverance, and boundless creativity. She was a published writer, an anchor on a children's news program, and a talented model and actress. Her passion for storytelling, music, and reading (especially anything by John Green) reflected her vibrant spirit and unwavering zest for life.
Even as she battled cancer, Holly never let her diagnosis define her. She continued to embrace life, cherishing moments with her beloved friends and family. Her humor, kindness, and ability to brighten any room were gifts that those who knew her will always carry in their hearts.
During Holly's long hospital stays, she and her family met many other families who shared heartbreaking stories of financial hardship while their children battled cancer. Holly wanted to help. Together with her mother, Christine Wade, she co-founded the Hands for Holly Fund, dedicated to assisting families in financial crisis with basic need expenses. The night before Holly passed, she and her family held the board organization meeting to officially establish the fund. Over the course of six years, the Hands for Holly Fund distributed more than $1 million to families in need, providing critical support during their most difficult times.
In honor of Holly's legacy, her mother, Christine Wade, continues to fight for sarcoma research funding and raise awareness of this rare cancer. As the Executive Director of the Paula Takacs Foundation, Christine is dedicated to advancing research and providing hope for those affected by sarcoma.
At the Paula Takacs Sarcoma Stomp, we honor not only Holly's memory but also Paula Takacs and all those who have been touched by this disease. Through raising awareness and funding research, we strive to create a future where sarcoma no longer claims lives and hope prevails.